Nuo Therapeutics, Inc. Income Statement
AURX|7 years of annual SEC 10-K data (FY2011-FY2017)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 7 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$721,045
FY2017
Gross Profit
-$369,997
-51.3% gross margin
Operating Income
-$16M
FY2017
Net Income
-$15M
FY2017
Nuo Therapeutics, Inc. reported $721,045 in revenue and $15M in net loss for FY2017. Revenue has declined at a 31.9% compound annual rate over the past 6 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -45.34 (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
- Negative return on equity: -3102.0% ROE
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|
| Revenue | $721.0K | $472.4K | $11.5M | $7.8M | $11.6M | $10.6M | $7.2M |
| Cost of Revenue | $1.1M | $729.0K | $8.0M | $6.8M | $8.5M | $3.9M | $2.7M |
| Gross Profit | -$370.0K | -$256.6K | $3.5M | $991.2K | $3.1M | $6.6M | $4.5M |
| SG&A Expense | $3.8M | $3.3M | $9.0M | $9.9M | $6.8M | $5.6M | $2.9M |
| R&D Expense | $1.3M | $1.0M | $2.6M | $4.0M | $3.8M | $3.4M | $98.1K |
| Operating Income | -$15.5M | -$5.5M | -$41.3M | -$23.4M | -$18.1M | -$12.9M | -$3.5M |
| Interest Expense | $10.8K | - | - | - | - | - | - |
| Income Tax | - | - | -$89.0K | $19.6K | $18.6K | $18.0K | $18.0K |
| Net Income | -$15.0M | -$5.7M | -$52.8M | -$18.9M | -$20.2M | -$19.8M | -$3.5M |
| EPS (Basic) | -$0.58 | -$0.58 | - | - | - | - | - |
| EPS (Diluted) | -$0.58 | -$0.58 | -$0.16 | -$0.20 | -$0.24 | -$0.08 | -$0.23 |
| Shares Outstanding | 9.9M | 125.7M | 125.7M | 107.2M | 93.8M | 55.5M | 44.1M |
| Gross Margin | -51.3% | -54.3% | 30.8% | 12.8% | 27.0% | 62.9% | 62.4% |
| Operating Margin | -2154.4% | -1155.3% | -359.0% | -301.4% | -156.4% | -122.1% | -48.5% |
| Profit Margin | -2077.4% | -1205.6% | -458.8% | -243.3% | -175.0% | -187.4% | -48.4% |